CD Genomics is a world-leading company that can provide the best microarray products and solutions for global customers in the field of transcriptomics research. We have successfully completed many related microarray projects and can provide the best products and services to customers all over the world.
Elucidating the genetic and non-genetic determinants of the complex pathophysiological process of biology is one of the main challenges of biomedical research. In recent years, genome-wide association studies (GWASs) have become an important strategy for studying the complete genetic basis of human complex diseases, helping to crack the secrets of most pathogenic genetic variants. To explore non-genetic variation is to understand the role of epigenetic factors in biological processes. The epigenome is highly dynamic, controlled by complex interactions with genetic and environmental factors. Normal cell function depends on the maintenance of epigenome homeostasis, which further highlights the many reported associations between epigenome perturbations and human diseases, especially cancer.
Our CpG microarray products can meet the needs of global measurement to the greatest extent. The detection range of the probe covers 27,800 CpG islands and about 450,000 methylation sites (approximately 21 Mb). Global analysis of DNA methylation changes that may be associated with key biological processes can be performed. In addition, we also provide corresponding professional software for methylation analysis, which can perform differentially methylated regions (DMRs) and methylation variable positions (MVPs) analysis to meet the personalized analysis needs of scientific researchers.
CD Genomics provides high-quality array products and services for epigenetics and methylation modification research. With a large team of scientists and a well-equipped test platform, we are committed to cooperating with customers all over the world to meet your specific requirements. We have comprehensive design and production capabilities to provide broad and comprehensive services for academic and industrial research. If you are interested in our products, please contact us for more details.
|Human CpG Island Microarray
Description: The microarray has been designed to maximize coverage and data quality. 237,220 unique probes in or within 95 bp of CpG Islands have been selected, enabling analysis of 27,800 CpG islands covering 21 MB of genome in a single experiment.
|Mouse CpG Island Microarray
Description: Mouse CpG microarrays enable a comprehensive insight into the DNA methylation changes that may be correlated to key biological processes. Such processes include cancer, development, genomic imprinting, gene silencing, and chromatin stability.